Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 36 | 2022 | 3443 | 2.850 |
Why?
|
| Artifacts | 6 | 2022 | 245 | 1.610 |
Why?
|
| Head | 6 | 2022 | 135 | 1.590 |
Why?
|
| Thermography | 3 | 2021 | 14 | 1.550 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2021 | 98 | 1.000 |
Why?
|
| Neck | 3 | 2022 | 103 | 0.960 |
Why?
|
| Contrast Media | 11 | 2018 | 1090 | 0.880 |
Why?
|
| Patient Safety | 2 | 2016 | 216 | 0.870 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2022 | 2657 | 0.850 |
Why?
|
| Protons | 4 | 2021 | 101 | 0.810 |
Why?
|
| Image Interpretation, Computer-Assisted | 11 | 2015 | 685 | 0.800 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 2 | 2021 | 43 | 0.790 |
Why?
|
| Prostate | 5 | 2018 | 393 | 0.790 |
Why?
|
| Brain | 8 | 2020 | 2281 | 0.760 |
Why?
|
| Dogs | 6 | 2018 | 704 | 0.710 |
Why?
|
| Image Enhancement | 10 | 2016 | 567 | 0.700 |
Why?
|
| Stroke | 2 | 2020 | 982 | 0.670 |
Why?
|
| White Matter | 1 | 2020 | 84 | 0.660 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 40 | 0.640 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2021 | 312 | 0.610 |
Why?
|
| Algorithms | 10 | 2018 | 1875 | 0.600 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2017 | 15 | 0.590 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 217 | 0.570 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1063 | 0.560 |
Why?
|
| Radiation Dosage | 3 | 2014 | 225 | 0.550 |
Why?
|
| Equipment Safety | 1 | 2016 | 33 | 0.540 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 129 | 0.530 |
Why?
|
| Thrombectomy | 1 | 2017 | 172 | 0.510 |
Why?
|
| Occupational Diseases | 1 | 2016 | 56 | 0.510 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2014 | 24 | 0.470 |
Why?
|
| Radiation Injuries | 1 | 2015 | 160 | 0.460 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2011 | 271 | 0.450 |
Why?
|
| Radiology | 1 | 2015 | 199 | 0.420 |
Why?
|
| Education, Medical | 1 | 2015 | 243 | 0.410 |
Why?
|
| Circle of Willis | 2 | 2011 | 5 | 0.400 |
Why?
|
| Neuronavigation | 5 | 2012 | 22 | 0.380 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 448 | 0.380 |
Why?
|
| Axilla | 1 | 2011 | 104 | 0.380 |
Why?
|
| Ultrasonography | 3 | 2021 | 711 | 0.380 |
Why?
|
| Neuroimaging | 1 | 2011 | 117 | 0.360 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 595 | 0.350 |
Why?
|
| Radiometry | 1 | 2010 | 56 | 0.350 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2015 | 302 | 0.340 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2019 | 1239 | 0.330 |
Why?
|
| Humans | 44 | 2022 | 89063 | 0.320 |
Why?
|
| Lymph Nodes | 1 | 2011 | 548 | 0.300 |
Why?
|
| Prostatic Neoplasms | 5 | 2018 | 1768 | 0.270 |
Why?
|
| Neurosurgical Procedures | 4 | 2013 | 232 | 0.270 |
Why?
|
| Burns | 3 | 2018 | 141 | 0.260 |
Why?
|
| Male | 21 | 2020 | 42251 | 0.260 |
Why?
|
| Reproducibility of Results | 14 | 2015 | 2752 | 0.250 |
Why?
|
| Sensitivity and Specificity | 12 | 2015 | 2014 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2014 | 295 | 0.240 |
Why?
|
| Bandages | 2 | 2018 | 41 | 0.240 |
Why?
|
| Gadolinium | 2 | 2017 | 103 | 0.230 |
Why?
|
| Risk Factors | 3 | 2020 | 5466 | 0.210 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2021 | 36 | 0.190 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 56 | 0.190 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 264 | 0.190 |
Why?
|
| Female | 18 | 2020 | 46011 | 0.190 |
Why?
|
| Silver Compounds | 2 | 2018 | 3 | 0.180 |
Why?
|
| Africa, Western | 1 | 2020 | 11 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 31 | 0.180 |
Why?
|
| Middle Aged | 16 | 2020 | 25863 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 168 | 0.180 |
Why?
|
| Aged | 12 | 2020 | 19077 | 0.170 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 145 | 0.170 |
Why?
|
| Subtraction Technique | 2 | 2012 | 132 | 0.170 |
Why?
|
| Craniotomy | 2 | 2011 | 88 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 34 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 988 | 0.170 |
Why?
|
| Emulsions | 1 | 2018 | 19 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 250 | 0.160 |
Why?
|
| Liver | 2 | 2019 | 1205 | 0.160 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 103 | 0.140 |
Why?
|
| Arteries | 1 | 2018 | 180 | 0.140 |
Why?
|
| Laser Therapy | 1 | 2018 | 149 | 0.140 |
Why?
|
| Temperature | 1 | 2017 | 400 | 0.140 |
Why?
|
| Cadaver | 6 | 2012 | 185 | 0.140 |
Why?
|
| Animals | 9 | 2019 | 27317 | 0.130 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 322 | 0.130 |
Why?
|
| Ear, Inner | 3 | 2012 | 33 | 0.130 |
Why?
|
| Safety Management | 1 | 2015 | 56 | 0.130 |
Why?
|
| Prostheses and Implants | 2 | 2013 | 124 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1755 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1591 | 0.120 |
Why?
|
| Retrospective Studies | 4 | 2017 | 9003 | 0.120 |
Why?
|
| Ejaculation | 1 | 2014 | 9 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 89 | 0.110 |
Why?
|
| Adult | 13 | 2017 | 26507 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 202 | 0.110 |
Why?
|
| Body Temperature | 1 | 2013 | 124 | 0.110 |
Why?
|
| Whole Body Imaging | 2 | 2010 | 41 | 0.110 |
Why?
|
| Equipment Design | 2 | 2013 | 415 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 111 | 0.110 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 11 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2011 | 779 | 0.100 |
Why?
|
| Microvessels | 1 | 2012 | 69 | 0.100 |
Why?
|
| Facial Nerve | 1 | 2012 | 34 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2008 | 754 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 3000 | 0.100 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 22 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2011 | 10 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 359 | 0.100 |
Why?
|
| Orbit | 1 | 2011 | 38 | 0.090 |
Why?
|
| Amides | 1 | 2011 | 53 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 336 | 0.090 |
Why?
|
| Echo-Planar Imaging | 1 | 2011 | 52 | 0.090 |
Why?
|
| Curriculum | 1 | 2015 | 567 | 0.090 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2011 | 71 | 0.090 |
Why?
|
| Carcinoma, Medullary | 1 | 2010 | 10 | 0.090 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 26 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 66 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 981 | 0.090 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2009 | 5 | 0.090 |
Why?
|
| Petrous Bone | 1 | 2009 | 11 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 364 | 0.090 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2009 | 25 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 315 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 66 | 0.090 |
Why?
|
| Brain Mapping | 2 | 2011 | 564 | 0.090 |
Why?
|
| Knee Joint | 1 | 2011 | 165 | 0.090 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 272 | 0.090 |
Why?
|
| Silver | 1 | 2009 | 16 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2014 | 2290 | 0.080 |
Why?
|
| United States | 3 | 2021 | 6955 | 0.080 |
Why?
|
| ROC Curve | 3 | 2019 | 781 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2010 | 190 | 0.080 |
Why?
|
| Pregnancy | 1 | 2016 | 3009 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 75 | 0.080 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 80 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2476 | 0.080 |
Why?
|
| Temporal Bone | 1 | 2008 | 66 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 589 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 459 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 315 | 0.080 |
Why?
|
| Infant | 1 | 2014 | 3147 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 121 | 0.070 |
Why?
|
| Swine | 2 | 2019 | 581 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2014 | 3717 | 0.070 |
Why?
|
| Auditory Perception | 1 | 2008 | 98 | 0.070 |
Why?
|
| Endoscopy | 1 | 2009 | 348 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 604 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 786 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 424 | 0.060 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 580 | 0.060 |
Why?
|
| Phospholipids | 1 | 2005 | 111 | 0.060 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 1214 | 0.060 |
Why?
|
| Adolescent | 2 | 2014 | 9237 | 0.060 |
Why?
|
| Child | 1 | 2014 | 7149 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 6777 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2013 | 308 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2014 | 337 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 661 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 781 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 214 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2014 | 8203 | 0.040 |
Why?
|
| Microbubbles | 1 | 2019 | 36 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2014 | 4273 | 0.040 |
Why?
|
| Pain, Procedural | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 865 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2018 | 208 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 996 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2011 | 575 | 0.040 |
Why?
|
| Young Adult | 3 | 2012 | 6288 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 104 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 1543 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 901 | 0.030 |
Why?
|
| Radio Waves | 1 | 2013 | 15 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 235 | 0.030 |
Why?
|
| Biomimetics | 1 | 2013 | 31 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 372 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2012 | 68 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 198 | 0.020 |
Why?
|
| Ascites | 1 | 2011 | 56 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 91 | 0.020 |
Why?
|
| Computers | 1 | 2011 | 112 | 0.020 |
Why?
|
| Titanium | 1 | 2010 | 20 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 96 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2012 | 485 | 0.020 |
Why?
|
| Microsurgery | 1 | 2011 | 88 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 657 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 5320 | 0.020 |
Why?
|
| Lasers | 1 | 2010 | 107 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2010 | 23 | 0.020 |
Why?
|
| Meglumine | 1 | 2010 | 38 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 225 | 0.020 |
Why?
|
| Cerebellopontine Angle | 1 | 2009 | 7 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 476 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 72 | 0.020 |
Why?
|
| Cranial Sinuses | 1 | 2009 | 15 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 116 | 0.020 |
Why?
|
| Deafness | 1 | 2009 | 48 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2009 | 30 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 610 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2009 | 15 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 114 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 70 | 0.020 |
Why?
|
| Contraindications | 1 | 2009 | 70 | 0.020 |
Why?
|
| Individuality | 1 | 2010 | 110 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 50 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 93 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 111 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 134 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 401 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2008 | 33 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 682 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2008 | 67 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 188 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1363 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 859 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 396 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 479 | 0.020 |
Why?
|
| Software | 1 | 2011 | 665 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 187 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2001 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2005 | 24 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 491 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 1889 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 221 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1650 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 3773 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1715 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 463 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2362 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4132 | 0.010 |
Why?
|